GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] the UK — has anyone got a straight answer on 503A — 48 comments in the full submission. View in context.
923
c/compounding·submitted 2 years ago by u/eu_apotheke_a

[Question] the UK — has anyone got a straight answer on 503A

Questionbranch of 4 comments

Posting this because I searched for it and got nothing useful. Setup: 10mg, week 65, injection-site soreness present but not ruining anything. I changed exactly one variable — state board — and tracked it for 9 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else…

Read the full submission and all 48 comments →

This branch

4 comments, started 2 years ago
u/formulary_fighterMOD81 points·2 years ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/honest_syringe65 points·2 years ago

Not to be pedantic but compounding and API source are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/chidi_demir18 points·2 years ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/gallbladder_gary14 points·2 years ago

Did they tell you their API source or dodge the question?

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →